User:Mr. Ibrahem/Alfuzosin

Alfuzosin, sold under the brand name Uroxatral among others, is a medication used to treat benign prostatic hyperplasia (BPH). It may be less effective than other medications in its class. It may be used together with a 5α-reductase inhibitors. It is taken by mouth once per day.

Common side effects include lightheadedness, tiredness, and headache. Other side effects include low blood pressure and QT prolongation. Use is not recommended in those with significant liver problems. It is a α1 adrenergic receptor blocker and works by relaxing the muscles in the prostate and bladder neck.

Alfuzosin was patented in 1978 and approved for medical use in 1988. It was approved for medical use in the United States in 2003. In the United States it costs about 18 USD for 3 months. In 2017, it was the 266th most commonly prescribed medication in the United States, with more than one million prescriptions.